4//SEC Filing
Butler John P. 4
Accession 0001562180-25-000917
CIK 0001517022other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:54 PM ET
Size
17.6 KB
Accession
0001562180-25-000917
Insider Transaction Report
Form 4
Butler John P.
DirectorCEO and President
Transactions
- Award
Common Stock
2025-01-31+701,000→ 2,748,580 total - Sale
Common Stock
2025-02-03$2.10/sh−46,268$97,163→ 2,702,312 total - Award
Stock Option (Right to buy)
2025-01-31+1,051,400→ 1,051,400 totalExercise: $2.24Exp: 2035-01-31→ Common Stock (1,051,400 underlying) - Sale
Common Stock
2025-02-03$2.10/sh−97,982$205,762→ 2,604,330 total - Award
Performance Stock Units
2025-01-31+350,500→ 350,500 totalExp: 2027-01-31→ Common Stock (350,500 underlying)
Holdings
- 100,000(indirect: Held By John Butler GRAT November 2019)
Common Stock
- 59,928(indirect: Held by Dorothy Butler 2019 GRAT)
Common Stock
- 59,928(indirect: Held by John Butler 2019 GRAT)
Common Stock
- 100,000(indirect: Held By Dorothy Butler GRAT November 2019)
Common Stock
Footnotes (7)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024 and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
- [F3]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.
- [F4]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023.
- [F5]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.
- [F6]Each Performance Stock Unit ("PSU") right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs shall vest on each of (a) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period, and (b) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $5.00 for over a 30-day trading period, subject to the reporting person's continued service with the Issuer through the applicable vesting date.
- [F7]The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001591467
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:54 PM ET
- Size
- 17.6 KB